Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Harmony Biosciences Holdings (HRMY) Leases (2020 - 2025)

Harmony Biosciences Holdings' Leases history spans 6 years, with the latest figure at $5.3 million for Q4 2025.

  • On a quarterly basis, Leases rose 151.84% to $5.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.3 million, a 151.84% increase, with the full-year FY2025 number at $5.3 million, up 151.84% from a year prior.
  • Leases hit $5.3 million in Q4 2025 for Harmony Biosciences Holdings, up from $1.2 million in the prior quarter.
  • Over the last five years, Leases for HRMY hit a ceiling of $5.3 million in Q4 2025 and a floor of $1.2 million in Q3 2025.
  • Historically, Leases has averaged $2.5 million across 5 years, with a median of $2.4 million in 2023.
  • The widest YoY moves for Leases: up 151.84% in 2025, down 49.08% in 2025.
  • Tracing HRMY's Leases over 5 years: stood at $3.3 million in 2021, then fell by 29.9% to $2.3 million in 2022, then increased by 1.38% to $2.3 million in 2023, then fell by 9.47% to $2.1 million in 2024, then soared by 151.84% to $5.3 million in 2025.
  • Business Quant data shows Leases for HRMY at $5.3 million in Q4 2025, $1.2 million in Q3 2025, and $1.3 million in Q2 2025.